The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3,5-difluorobenzyl)-5-(2-oxo-2H-chromen-6-yl)-1H-pyrrole-2-carbonitrile ID: ALA3983437
PubChem CID: 134157750
Max Phase: Preclinical
Molecular Formula: C21H12F2N2O2
Molecular Weight: 362.33
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1ccc(-c2ccc3oc(=O)ccc3c2)n1Cc1cc(F)cc(F)c1
Standard InChI: InChI=1S/C21H12F2N2O2/c22-16-7-13(8-17(23)10-16)12-25-18(11-24)3-4-19(25)14-1-5-20-15(9-14)2-6-21(26)27-20/h1-10H,12H2
Standard InChI Key: NIDQVGMQJYGJEB-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
20.8411 -18.1144 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8399 -18.9339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5480 -19.3429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5462 -17.7055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2548 -18.1108 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2582 -18.9360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9706 -19.3434 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.6841 -18.9301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6808 -18.1049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9638 -17.6930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3930 -19.3368 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.1378 -17.7062 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0519 -16.8940 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.2527 -16.7238 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8443 -17.4317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3913 -18.0388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9239 -15.9769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5913 -15.2304 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.7587 -16.4837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7568 -15.6665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4631 -15.2608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4615 -14.4444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7523 -14.0366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0433 -14.4512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0483 -15.2663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1685 -14.0345 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
19.3332 -14.0468 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
8 11 2 0
12 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 2 0
1 12 1 0
17 18 3 0
14 17 1 0
13 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
22 26 1 0
24 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 362.33Molecular Weight (Monoisotopic): 362.0867AlogP: 4.46#Rotatable Bonds: 3Polar Surface Area: 58.93Molecular Species: ┄HBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.44CX LogD: 4.44Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.51Np Likeness Score: -0.84
References 1. Kinoshita M, Negishi M, Sakai H, Hirano T, Mori S, Fujii S, Kagechika H, Tanatani A.. (2016) Development of 6-arylcoumarins as nonsteroidal progesterone antagonists. Structure-activity relationships and fluorescence properties., 24 (21): [PMID:27665178 ] [10.1016/j.bmc.2016.09.020 ]